EMPLOYMENT AGREEMENT
Exhibit
10.34
THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of February 7, 2007
(the “Effective Date”) by and between Luminex Corporation, a Delaware corporation (“Luminex”) and
Xxxx X. Xxxxxxx (“Executive”).
RECITAL
WHEREAS, Executive is employed as the Vice President, Research & Development for Luminex;
WHEREAS, Luminex and Executive wish to document the terms of the employment of Executive in
such capacity; and
WHEREAS, Executive has represented to Luminex and Luminex has relied on Executive’s
representation that the execution of this Agreement by Executive, and the provision of services by
Executive to Luminex as contemplated in this Agreement, will not conflict with, or cause Executive
or any other person or entity to be in breach of, (i) any other contract to which Executive is a
party or (ii) any duty which Executive may owe to any other person or entity.
AGREEMENT
NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is
hereby acknowledged, the parties agree as follows:
1. Duties.
1.1 Duties. During the term of this Agreement (including all renewal periods, if any,
the “Term”), Executive agrees to be employed by and to serve as Vice President, Research and
Development, and Luminex agrees to employ and retain Executive in such capacity subject to the
provisions of this Agreement. Executive shall have such powers, authority and duties, and shall
render such services of executive and administrative character, or act in such other capacity for
Luminex, as the Chief Executive Officer or the Board of Directors of Luminex (the “Board”) shall
from time to time lawfully direct, and Executive shall report directly to the Chief Executive
Officer of Luminex. Executive shall devote all of his business time, energy, and skill to the
business of Luminex.
2. Term and Termination.
2.1 Term. Subject to Section 2.2, the term of employment of Executive by Luminex
shall be one (1) year commencing on the Effective Date and shall thereafter automatically renew for
successive additional one-year terms unless either party provides the
other with written notice of
its intent not to renew this Agreement at least sixty (60) days prior to the end of the Term
(unless terminated earlier pursuant to the provisions of this Agreement).
2.2 Termination of Employment.
2.2.1 Termination For Cause. “Termination For Cause” shall mean the termination by
Luminex of Executive’s employment with Luminex as the result of Executive’s material fraud upon
Luminex or Executive’s continued material breach of this Agreement after receipt of written notice
from Luminex specifying such breach and failure by Executive to cure such breach within fifteen
(15) days from receipt of such notice. Executive’s inability to perform his obligations under this
Agreement despite his best efforts as a result of a permanent or temporary disability (as evidenced
by a written determination from a physician chosen by Executive and reasonably acceptable to
Luminex) shall not result in a Termination For Cause. In the event that Executive fails to cure
the breach within the fifteen (15) day cure period, the termination shall be effective as of the
date that Luminex notifies Executive of his termination following the expiration of the fifteen
(15) day cure period. Upon any Termination For Cause, Executive shall be paid the Accrued
Obligations (defined below) within three (3) business days following the effective date of
termination.
2.2.2 Termination Other Than For Cause. “Termination Other Than For Cause” shall mean
(i) termination by Luminex of Executive’s employment with Luminex for any reason other than
Termination For Cause, Termination by Reason of Death, Termination by Reason of Incapacity or
Termination Upon Expiration of Agreement or (ii) termination by Executive upon constructive
termination of Executive’s employment with Luminex by reason of (A) a reduction in Executive’s Base
Salary (defined below); (B) a reduction in Executive’s title from Vice President, Research &
Development for Luminex (whether by reason of Executive’s removal from any of such offices or
Luminex’s failure to reappoint Executive to any of such offices); (C) a Material Diminution
(defined below); (D) a requirement that Executive change his principal place of business to a
location that is outside the Office Area (defined below), or (E) Luminex’s continued material
breach of this Agreement after receipt of written notice from Executive specifying such breach and
failure by Luminex to cure such breach within fifteen (15) days from receipt of such notice.
Termination Other Than For Cause may be effected by Luminex at any time by providing Executive with
written notice of such termination. The termination shall be effective as of the date of the
notice or such later date as may be determined by Luminex. Executive may also effect a Termination
Other Than For Cause upon written notice to Luminex at any time any of the conditions for
constructive termination set forth in clause (ii) above (including without limitation, if
applicable, the expiration of the cure period) have been met. Upon any Termination Other Than For
Cause, Executive shall be paid (i) within three (3) business days following the effective date of
termination the amount of the Accrued Obligations and (ii) all severance compensation provided in
Section 4.1. For purposes of this Agreement, “Material Diminution” means a material diminution by
Luminex of Executive’s duties, powers, authority, functions or responsibilities without Executive’s
consent, such that Executive is left with such duties, powers, authority, functions and
responsibilities (when viewed in the aggregate) that are materially diminished compared to both (i)
those duties, powers,
- 2 -
authority, functions and responsibilities conferred upon Executive at the
Effective Date and (ii) those duties, powers, authority, functions and responsibilities that are
most typically conferred upon the employee vice president of research and development of companies
having both (i) an employee vice president of research and development and (ii) revenues comparable
to Luminex (based on the revenues of Luminex at the time of determination). Luminex and Executive agree
that in the event there is an ambiguity with respect to the interpretation or application of the
definition of “Material Diminution”, such ambiguity shall be resolved according to the reasonable
interpretation of such definition most favorable to Luminex. For purposes of this Agreement,
“Office Area” means the geographical area within a 40 mile radius of Luminex’s current principal
office at 00000 Xxxxxxxxxx Xxxx., Xxxxxx, Xxxxx.
2.2.3 Actual Voluntary Termination. “Actual Voluntary Termination” shall mean
termination by Executive of Executive’s employment with Luminex for any reason other than
Termination For Cause, Termination Other Than For Cause, Termination by Reason of Death or
Termination by Reason of Incapacity. In the event of an Actual Voluntary Termination, Executive
shall be paid within fifteen (15) business days following the effective date of termination the
amount of the Accrued Obligations.
2.2.4 Termination by Reason of Incapacity. If, during the Term, Executive shall
become Permanently Disabled (defined below), Luminex may terminate Executive’s employment with
Luminex effective on the earliest date permitted under applicable law, if any, and such termination
shall be deemed “Termination by Reason of Incapacity”. Upon termination of employment under this
Section, Executive shall be paid (i) within three (3) business days following the effective date of
termination the amount of the Accrued Obligations and (ii) all severance compensation provided in
Section 4.2. As used herein, Executive shall be deemed “Permanently Disabled” if Executive is (i)
collecting long-term disability payments under a long-term disability plan established for the
benefit of Luminex’s employees or executives generally or a reasonably similar plan or (ii) if, and
only if, no such long-term disability plan is in effect at the time of determination, a physician
selected by Luminex and reasonably acceptable to Executive makes a written determination that
Executive is unable to perform his obligations under this Agreement despite his best efforts by
reason of any medically determinable physical or mental impairment that can be expected to result
in death or that has lasted or can be expected to last for a continuing period of not less than 12
months.
2.2.5 Termination by Reason of Death. In the event of Executive’s death during the
Term, Executive’s employment with Luminex shall be deemed to have terminated as of the date on
which his death occurs and the estate of Executive shall be paid (i) within fifteen (15) days
following the effective date of termination the amount of the Accrued Obligations and (ii) all
severance compensation provided in Section 4.3.
2.2.6 Termination Upon Expiration of Agreement. In the event that Luminex refuses for
any reason to extend this Agreement by giving written notice at least 60 days prior to the initial
or any renewal period as set forth in Section 2.1, Executive shall be paid (i) within three (3)
business days following the effective date of termination the amount of the Accrued Obligations and
(ii) all severance compensation provided in Section 4.4. In the event
- 3 -
that Executive refuses for
any reason (except as otherwise provided herein) to extend this Agreement by giving written notice
at least 60 days prior to the initial or any renewal period as set forth in Section 2.1, the
termination shall be deemed an Actual Voluntary Termination.
2.2.7 Termination of Relationship with Affiliated Entities. Unless agreed by Luminex
(or a subsidiary thereof) and Executive in a separate written agreement (other than corporate
minutes, resolutions, charter documents, bylaws and partnership agreements), upon the termination
of Executive’s employment with Luminex for any reason, Executive shall tender a written resignation
of any positions he may have with Luminex and any and all of Luminex’s direct and indirect
subsidiaries.
2.2.8 Definition of Accrued Obligations. As used in this Agreement, “Accrued
Obligations” means all accrued but unpaid salary, accrued but unpaid vacation, sick leave, and
similar pay (all determined in accordance with Luminex’s policies then in effect), and any
appropriate business expenses incurred by Executive in connection with his duties hereunder, all to
the date of termination.
3. Salary, Benefits and Bonus Compensation.
3.1 Base Salary. As payment for the services to be rendered by Executive as provided
in Section 1 and subject to the terms and conditions of Section 2, Luminex agrees to pay to
Executive a “Base Salary” at the rate of $8,125 per each semi-monthly pay period or $195,000 per
annum (or such greater amount as may be determined from time to time by the Board or the
Compensation Committee thereof) payable in accordance with the then-current payroll policies of
Luminex.
3.2 Annual Bonus. Beginning with calendar year 2007, Executive shall be eligible to
receive a bonus each year in an amount up to at least 40% of your then-current Base Salary (or such
other amount as may otherwise be determined by Luminex’s Board of Directors), subject to the
performance criteria established annually by Luminex’s Board of Directors and payable during the
first quarter of the following year or otherwise as consistent with the timing of other employee
bonuses. The Board is under no obligation to declare, and Luminex is under no obligation to pay,
any bonus to Executive under the terms of this Agreement. In the event Executive and Luminex are
parties to a written agreement or plan executed by both Luminex and Executive that governs bonus
arrangements, and the provisions thereof conflict with this Section 3.2, the terms of such other
written agreement or plan shall supersede this Section 3.2.
3.3 Change in Control. In the event that both (i) a Change in Control (defined below)
of Luminex occurs during the Term and (ii) Executive’s employment with Luminex (or, as applicable,
its successor in interest) terminates for any reason (including without limitation an Actual
Voluntary Termination by Executive) at any time within six (6) months following the occurrence of
the Change in Control of Luminex, in lieu of any Severance Compensation then owed or that otherwise
would be owed in the future to Executive under Section 4 of this Agreement, Luminex (or its
successor in interest) shall pay Executive both the Accrued Obligations and a lump sum payment (the
“Change in Control Payment”) in an aggregate
- 4 -
amount equal to the sum of (i) the Bonus Amount
(defined below), plus (ii) an amount equal to Executive’s annual Base Salary (at the highest rate
in effect during the period beginning six months immediately prior to the effective date of the
Change of Control through the date of termination) within, subject to Section 4.8, three (3)
business days after the termination of Executive’s employment. In the interest of clarity, Luminex
and Executive agree that, upon the termination of Executive’s employment at any time within six (6) months following the
occurrence of the Change in Control of Luminex, the provisions of Sections 4.1, 4.2, 4.3, 4.4, and
4.6 shall automatically be deemed null and void and shall not apply with respect to any termination
of Executive’s employment (whether such termination is effected in connection with the Change in
Control of Luminex or at any time in the future following the Change in Control of Luminex), and
under no circumstances shall Luminex ever be obligated to pay Executive both a Change in Control
Payment and Severance Compensation under Section 4. For purposes of this Agreement, a “Change in
Control” of Luminex shall be deemed to have occurred if, after the date of this Agreement:
(A) any “Person” (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange
Act of 1934, as amended (the “Exchange Act”)) (other than an Approved Person (as defined below))
becomes the “Beneficial Owner” (as defined in Rule 13d-3 under the Exchange Act), directly or
indirectly, of a majority or more of the then outstanding Common Stock of Luminex (“Common
Stock”) (such Person, an “Acquiring Person”); or
(B) Luminex merges or consolidates with any other corporation or other entity, in each case
other than a merger or consolidation which results in the voting securities of Luminex outstanding
immediately prior thereto continuing to represent (either by remaining outstanding or by being
converted into voting securities of the surviving entity) at least a majority of the combined
voting power of the voting securities of Luminex or such surviving entity outstanding immediately
after such merger or consolidation; or
(C) Luminex sells or disposes of all or substantially all of Luminex’s assets in one
transaction or a series of related transactions; or
(D) Luminex files a periodic or current report or proxy statement with the Securities and
Exchange Commission (the “SEC”) disclosing that a “change in control” (as such term is used in Item
5.01 of Form 8-K promulgated by the SEC) of Luminex has occurred; or
(E) If, as a result of nominations made by a person or group other than the Board of Directors
of Luminex, individuals who prior to such nominations constitute the Directors of Luminex cease for
any reason to constitute at least a majority thereof within the two year period following such
nominations.
As used in this Agreement, “Approved Person” means (1) an employee benefit plan of Luminex (or
a trustee or other fiduciary holding securities for such a plan), or (2) a corporation owned,
directly or indirectly, by the stockholders of Luminex in substantially the same proportions as
their ownership of stock of Luminex, or (3) a Person not less than a majority of
- 5 -
whose voting securities are Beneficially Owned by Luminex after giving effect to the transaction.
As used in this Agreement, “Bonus Amount” means the annual bonus (if any) received or to be
received by Executive under Section 3.2 in respect of the then most recently completed calendar
year, or if no determination concerning bonuses has been made for the most recently completed
calendar year, then the annual bonus (if any) for the previous calendar year.
Any options (“Options”) granted (including without limitation Options that may be granted in
the future) and restricted stock (“Restricted Stock”) issued (including without limitation
Restricted Stock that may be issued in the future) to Executive pursuant to any incentive plan of
Luminex shall immediately vest upon a Change in Control. Luminex shall take no action to
facilitate a transaction involving a Change in Control, including without limitation redemption of
any rights issued pursuant to any rights agreement, unless it has taken such action as may be
necessary to ensure that Executive has the opportunity to exercise all Options he may then hold,
and obtain certificates containing no restrictive legends in respect of any Restricted Stock he may
then hold, at a time and in a manner that shall give Executive the opportunity to sell or exchange
the securities of Luminex acquired upon exercise of his Options and upon receipt of unrestricted
certificates for shares of Common Stock in respect of his Restricted Stock, if any (collectively,
the “Acquired Securities”), at the earliest time and in the most advantageous manner any holder of
the same class of securities as the Acquired Securities is able to sell or exchange such securities
in connection with such Change in Control. Luminex acknowledges that its covenants in the preceding
sentence (the “Covenants”) are reasonable and necessary in order to protect the legitimate
interests of Luminex in maintaining Executive as one of its employees and that any violation of the
Covenants by Luminex would result in irreparable injuries to Executive, and Luminex therefore
acknowledges that in the event of any violation of the Covenants by Luminex or its directors,
officers or employees, or any of their respective agents, Executive shall be entitled to obtain
from any court of competent jurisdiction temporary, preliminary and permanent injunctive relief in
order to (i) obtain specific performance of the Covenants, (ii) obtain specific performance of the
exercise of his Options, delivery of certificates containing no restrictive legends in respect of
his Restricted Stock and the sale or exchange of the Acquired Securities in the advantageous manner
contemplated above or (iii) prevent violation of the Covenants; provided nothing in this Agreement
shall be deemed to prejudice Executive’s rights to damages for violation of the Covenants. In the
event that the terms of any separate written agreement concerning Options granted or Restricted
Stock issued to Executive conflict with the terms of this paragraph, the terms of this paragraph
shall control.
3.4 Additional Benefits. During the Term, Executive shall be entitled to the
following fringe benefits:
3.4.1 Benefits and Vacation. Executive shall be eligible to participate in such of
Luminex’s benefits and deferred compensation plans as are now generally available or later made
generally available to executive officers of Luminex. A termination or expiration of this
Agreement for any reason or for no reason shall not affect any rights which Executive may have
pursuant to any agreement, policy, plan, program or arrangement of Luminex providing
- 6 -
Executive benefits (including under any stock option agreement or bonus plan or agreement which may exist),
which rights shall be governed by the terms thereof. Executive shall be entitled to three (3)
weeks paid vacation each calendar year (prorated for partial years). Unless approved in advance by
the Board or a committee thereof, accrued vacation not taken in any applicable period shall not be
carried forward or used in any subsequent period.
3.4.2 Reimbursement for Expenses.
3.4.2.1 Incidental Expenses. Luminex shall reimburse Executive for reasonable and
properly documented out-of-pocket business and/or entertainment expenses incurred by Executive in
connection with his duties under this Agreement. Any such expenses shall be submitted by Executive
to Luminex on a periodic basis and will be paid in accordance with standard Luminex policies and
procedures.
3.4.2.2 Moving Expenses. In the event of the relocation of Luminex’s headquarters to
a location that is outside the Office Area and Executive elects to relocate, Luminex shall (i)
reimburse Executive for any reasonable, out-of-pocket and adequately documented moving expenses
incurred by Executive in connection with the transfer of his residence and (ii) pay to an Executive
an amount of cash reasonably calculated by Luminex to negate adverse income tax consequences to
Executive of the foregoing reimbursement.
4. Severance Compensation.
4.1 Severance Compensation in the Event of a Termination Other Than For Cause. In the
event Executive’s employment is terminated as a result of a Termination Other Than for Cause,
Executive shall be paid (subject to Section 4.6) the Severance Compensation (defined below).
4.2 Severance Compensation for Termination by Reason of Incapacity. In the event
Executive’s employment is terminated as a result of a Termination by Reason of Incapacity,
Executive shall be paid (subject to Section 4.6) the difference of (i) the Severance Compensation
less (ii) any payment or payments received by Executive during the twelve (12) month period from
the time of termination under any long-term disability plan in effect that provides benefits to
Executive.
4.3 Severance Compensation for Termination by Reason of Death. In the event
Executive’s employment is terminated as a result of Executive’s death, the estate of Executive
shall be paid the Severance Compensation.
4.4 Severance Compensation In the Event Of A Failure Of Luminex To Renew This
Agreement. In the event Luminex fails or otherwise refuses for any reason to extend this
Agreement beyond the Term and any extensions thereof, Executive shall be paid (subject to Section
4.6) the Severance Compensation.
- 7 -
4.5 No Severance Compensation Upon Other Termination. In the event of an Actual
Voluntary Termination or Termination For Cause, Executive shall not be paid any severance
compensation.
4.6 Conditions to Payment; Sole Remedy. Executive shall not be entitled to receive
any compensation or other payment pursuant to Sections 4.1, 4.2 or 4.4 unless Executive shall have
executed and delivered to Luminex a release substantially in the form attached hereto as
Exhibit “A” and, provided Luminex has also signed such release within two (2) business days
of execution and delivery by Executive, all revocation and waiting periods applicable to such
release have expired (if Luminex fails to sign such release, then such revocation and waiting
periods shall not apply). In addition, in the event that Executive breaches any of the restrictive
covenants set forth in Article 5 at any time, Luminex shall be entitled to discontinue any
compensation or other payments pursuant to Sections 4.1, 4.2 or 4.4 (provided, however, that if it
is finally determined by a court of competent jurisdiction or an arbitrator that Luminex asserted
in bad faith that Executive breached any of the restrictive covenants set forth in Article 5, the
payments of the Severance Compensation shall be extended for two months for each calendar month
that payments were delayed. The compensation to be paid to Executive pursuant to Sections 4.1,
4.2, 4.3 or 4.4 shall represent the sole and exclusive remedy of Executive in connection with the
termination of his employment and this Agreement upon a Termination Other Than for Cause, a
Termination by Reason of Incapacity, a termination in connection with Executive’s death, or a
refusal by Luminex to extend this Agreement beyond the Term and any extensions thereof.
4.7 Definition of Severance Compensation. As used in this Agreement, “Severance
Compensation” means an amount equal to the sum of (i) the Bonus Amount plus (ii) an amount equal to
Executive’s annual Base Salary (at the highest rate in effect for the six month period immediately
prior to the date of termination), paid in semi-monthly installments for a period of twelve (12)
months from the date of termination. In addition, as part of the Severance Compensation, Luminex
also shall pay (until the earlier of (A) the first annual anniversary of the termination of this
Agreement or (B) the date that Executive is eligible to be covered under a comparable or more
favorable health plan of another Person) (i) COBRA premiums in respect of the continuation of
health benefits for Executive, his spouse and his children and (ii) payments to fund dental
coverage for Executive, his spouse and his children comparable to the dental coverage that they
would have received if Executive had continued as an employee of Luminex. Executive acknowledges
that the cost of COBRA and dental premiums described in this Section 4.7 shall be reportable as
taxable income to Executive.
4.8 Six Month Delay for Certain Payments. In the event the payment of any amounts
payable pursuant to this Section 4 (or Section 3) hereof (including COBRA and dental premiums)
within six months of the date of Executive’s termination of employment would cause Executive to
incur any additional tax under Section 409A of the Internal Revenue Code, as amended, then payment
of such amounts shall be delayed until the date that is six months following executive’s
termination date (the “Earliest Payment Date”). If this provision becomes applicable, it is
anticipated that payments that would have been made prior to the Earliest
- 8 -
Payment Date in the absence of this provision would be paid as a lump sum on the Earliest Payment Date and the
remaining severance benefits or other payments would be paid according to the schedule otherwise
applicable to the payments.
5. Protection of Luminex.
5.1 Non-Competition. Ancillary to the otherwise enforceable agreements set forth in
this Agreement, Executive agrees that during Executive’s employment with Luminex and for a period
of one year following termination of employment, whether such termination occurs at the insistence
of Executive or Luminex for any reason, Executive shall not compete
directly or indirectly in any way with the business of Luminex anywhere in the world where
Luminex conducted business during the Term. For purposes of this Agreement, “compete directly or
indirectly in any way with the business of Luminex” means to become an employee, consultant,
advisor, manager, member, director of or beneficially own more than three percent of any
individual, company or entity that competes with Luminex in the Core Business (defined below) at
the time of determination. Executive agrees that the assertion or existence of any claim by
Executive against Luminex shall not be a defense to the enforcement of this paragraph by injunction
or otherwise. As used in this Agreement, “Core Business” means the development, manufacturing
and/or marketing of multiplexing biological testing technologies with applications in the
life-sciences industry.
5.2 Nonsolicitation. Ancillary to the otherwise enforceable agreements set forth in
this Agreement, Executive agrees that, for a period of one (1) year subsequent to the termination
of Executive’s employment with Luminex, whether such termination occurs at the insistence of
Executive or Luminex for any reason, Executive shall not recruit, hire, or attempt to recruit or
hire, directly or by assisting others, any other employees of Luminex, nor shall Executive contact
or communicate with any other employees of Luminex for the purpose of inducing other employees to
terminate their employment with Luminex. For purposes of this covenant, “other employees of
Luminex” shall refer to employees who are still actively employed by, or doing business with,
Luminex or a subsidiary of Luminex at the time of the attempted recruiting or hiring.
5.3 Remedies. Due to the irreparable and continuing nature of the injury which would
result from a breach of the covenants described in Sections 5.1 and 5.2, Executive agrees that
Luminex may, in addition to any remedy which Luminex may have at law or in equity, apply to any
court of competent jurisdiction for the entry of an immediate order to restrain or enjoin the
breach of this covenant and to otherwise specifically enforce the provisions of the covenants set
forth in Sections 5.1 and 5.2.
5.4 Acknowledgment. Executive acknowledges and agrees that the restrictions set forth
above are ancillary to an otherwise enforceable agreement and supported by independent valuable
consideration as required by Tex. Bus. & Comm. Code Xxx. § 15.50. Executive further
acknowledges and agrees that the limitations as to time, geographical area, and scope of activity
to be restrained by Sections 5.1 and 5.2 are reasonable and acceptable to
- 9 -
Executive, and do not impose any greater restraint than is reasonably necessary to protect the goodwill and other
business interests of Luminex.
5.5 Reformation and Severance. If a judicial determination is made that any of the
provisions of the above restriction constitutes an unreasonable or otherwise unenforceable
restriction against Executive, it shall be rendered void only to the extent that such judicial
determination finds such provisions to be unreasonable or otherwise unenforceable. In this regard,
the parties hereby agree that any judicial authority construing this Agreement shall be empowered
to sever any portion of the prohibited business activity from the coverage of this restriction and
to apply the restriction to the remaining portion of the business activities not so severed by such
judicial authority. Moreover, notwithstanding the fact that any provisions of this restriction are
determined by a court not to be specifically enforceable through injunctive relief,
Luminex shall nevertheless be entitled to seek to recover monetary damages as a result of the
breach of any provision which is not reformed by a court. The time period during which the
restrictions shall apply shall be tolled and suspended as to Executive for a period equal to the
aggregate quantity of time during which Executive violates such prohibitions in any respect.
5.6 Confidential Information and Trade Secrets. As used herein, “Confidential
Information” means any data or information that is important, competitively sensitive, and not
generally known by the public or persons involved in the biological testing or life sciences
industries, including, but not limited to, Luminex’s business plans, prospective customers,
training manuals, proprietary software, product development plans, bidding and pricing procedures,
market plans and strategies, projections, internal performance statistics, financial data,
confidential personnel information concerning employees of Luminex, operational or administrative
plans, policy manuals, and terms and conditions of contracts and agreements. The term
“Confidential Information” shall not apply to information which is (i) already in Executive’s
possession (unless such information was obtained by Executive from Luminex in the course of
Executive’s employment by Luminex); (ii) received by Executive from a third party with, to
Executive’s knowledge, no restriction on disclosure or (iii) required to be disclosed by any
applicable law or by an order of a court of competent jurisdiction.
Executive recognizes and acknowledges that the Confidential Information constitutes valuable,
special and unique assets of Luminex and its affiliates. Except as required to perform Executive’s
duties as an Executive of Luminex, until such time as they cease to be Confidential Information
through no act of Executive in violation of this Agreement, Executive will not use or disclose any
Confidential Information of Luminex. Upon the request of Luminex and, in any event, upon the
termination of this Agreement for any reason, Executive will surrender to Luminex (i) all
memoranda, notes, records, drawings, manuals or other documents pertaining to Luminex’s business
including all copies and/or reproductions thereof and (ii) all materials involving any Confidential
Information of Luminex.
5.7 Preservation of Luminex Property. Executive acknowledges that from time to time
in the course of employment with Luminex, Executive has had the opportunity to inspect and use
certain property of Luminex, both tangible and intangible, including but not limited to files,
records, documents, drawings, specifications, lists, equipment, graphics, designs,
- 10 -
and similar items relating to the business of Luminex. Executive acknowledges and agrees that all such
property, including but not limited to any and all copies thereof, whether prepared by Executive or
otherwise in the possession of Executive, are and shall remain the exclusive property of Luminex,
that Executive shall have no right or proprietary interest in such property and that Executive will
safeguard and return to Luminex all such property upon the earlier of (i) Luminex’s request and
(ii) the termination of Executive’s employment with Luminex.
5.8 Assignment of Inventions to Luminex. All computer software, compilations,
programs, improvements, inventions, notes, copyrightable works, and opportunities for additional
Luminex business, made, fixed, conceived, or acquired by Executive during the Term are exclusively
owned by Luminex, are Luminex’s works for hire, and fully assigned to Luminex including without
limitation all rights to renewals, extensions, causes of action, reproduce, prepare derivative
works, distribute, display, perform, transfer, make, use and
sell and may never be copied, used, or disclosed without Luminex’s express written consent.
Executive will sign on request any documents affirming the same for any particular item. In
addition, Executive agrees to execute Luminex’s standard Confidentiality and IP Assignment
Agreement by the Effective Date to the extent Executive has not already executed such an agreement.
5.9 Notice to Subsequent Employers. Executive agrees that, prior to commencing any
new employment in the Core Business within twelve months after the termination of this Agreement,
Executive will furnish the new employer with a copy of this Agreement. Executive also agrees that
Luminex may advise any new or prospective employer of the existence and terms of this Agreement and
furnish the employer with a copy of this Agreement.
6. Disclosure of Investments. Commencing upon Executive’s execution of this Agreement
and at all times during the Term, Executive shall keep the Board informed in writing of the nature
and extent of Executive’s investments, stock holdings, or retention as a director, advisor or any
similar interest in any business or enterprise involved in the Core Business other than Luminex;
provided, however, that Executive shall not be required to disclose any such investments or stock
holdings that constitute less than 1% of such entity’s total obligations or total voting power.
7. Arbitration.
7.1 Exclusive Remedy. Arbitration shall be the sole and exclusive remedy for
resolving any claim or dispute which cannot be mutually resolved between the parties to this
Agreement with the exception of disputes arising out of Executive’s obligations under Article 5 or
disputes arising out of Luminex’s obligations under the last paragraph of Section 3.3, which are
not subject to this arbitration provision; provided however, that the parties hereto agree that
they may bring action in any court of competent jurisdiction to enforce any award granted pursuant
to arbitration or to otherwise enforce this Article 7. This includes, but is not limited to,
termination, interpretation or application of this Agreement or any other agreement or policy of
Luminex, any claim of violation of law relating to the employment relationship, including,
- 11 -
without limitation, any claim of employment discrimination or sexual harassment, or harassment based on any
other prohibited basis, or any claim by Luminex against Executive. This Agreement is a waiver of
the right to trial by a jury or court.
7.2 Limitations. The request for arbitration must be made within one (1) year from
the date of the occurrence giving rise to the dispute or claim; or, in the event of a statutory
claim, the time set forth by statute.
7.3 Rules and Procedures. The arbitration will be conducted under the rules and
procedures for arbitration of employment disputes of the American Arbitration Association. The
arbitration shall take place in Austin, Texas unless the parties mutually agree to another
location.
7.4 Arbitrator’s Authority. Upon finding that a claim is meritorious or in favor of
one of the parties to the dispute, the arbitrator or arbitrators shall have the authority to order
legal and equitable remedies appropriate as permitted by law.
7.5 Expenses. Costs of obtaining and paying the arbiter and the costs associated with
conducting the arbitration, including obtaining a facility to be used during the arbitration, shall
be paid by Luminex. Other costs of the arbitration or any litigation associated with any dispute
arising under or in connection with this Agreement including, without limitation, reasonable
attorneys’ and experts’ fees and expenses of Luminex and the Executive shall be borne by the party
incurring such expense unless the arbiter or court of law, as the case may be, awards costs to one
of the parties.
8. Miscellaneous.
8.1 Waiver. The waiver of the breach of any provision of this Agreement shall not
operate or be construed as a waiver of any subsequent breach of the same or other provision hereof.
8.2 Entire Agreement; Modifications. Except as otherwise provided herein, this
Agreement represents the sole, entire, and complete understanding among the parties with respect to
the subject matter hereof, and this Agreement supersedes any and all prior understandings,
agreements, plans and negotiations, whether written or oral, with respect to the subject matter
hereof, including without limitation any understandings, agreements or obligations respecting any
past or future compensation, bonuses, reimbursements or other payments to Executive from Luminex.
All modifications to the Agreement must be in writing and signed by both Executive and Luminex.
8.3 Notices. All notices and other communications under this Agreement shall be in
writing and shall be given by facsimile or first class mail, certified or registered with return
receipt requested, and shall be deemed to have been duly given three business days after mailing or
one business day after transmission of a facsimile (with confirmation of receipt) to the respective
persons named below:
- 12 -
| If to Luminex: | Luminex Corporation | |||
| Attn: General Counsel | ||||
| 12000 Xxxxxxxxxx Xxxx. | ||||
| Xxxxxx, Xxxxx 00000 | ||||
| Fax: (000) 000-0000 | ||||
| If to Executive: | Xxxx X. Xxxxxxx | |||
| 300 Xxxxxx Xx. | ||||
| Xxxxxx, XX 00000 |
Any party may change such party’s address for notices by notice duly given pursuant to this Section
8.3.
8.4 Headings. The Section headings herein are intended for reference and shall not by
themselves determine the construction or interpretation of this Agreement.
8.5 Governing Law; Venue. This Agreement shall be governed by and construed in
accordance with the laws of the State of Texas. Subject in all respects to Section 7 generally and
Section 7.3 in particular, any dispute arising out of or relating to this Agreement may be brought
in a court of competent jurisdiction located in Austin, Texas, and both of the parties to this
Agreement irrevocably submit to the exclusive jurisdiction of such courts in any such dispute,
waives any objection it may now or hereafter have to venue or to convenience of forum, agrees that
all claims in respect of the dispute shall be heard and determined only in any such court, and
agrees not to bring any dispute arising out of or relating to this Agreement in any other court.
The parties agree that either or both of them may file a copy of this paragraph with any court as
written evidence of the knowing, voluntary and bargained agreement among the parties irrevocably to
waive any objections to venue or to convenience of forum. Process in any dispute may be served on
any party anywhere in the world.
8.6 Severability. Should any court of competent jurisdiction determine that any
provision of this Agreement is illegal or unenforceable to any extent, such provision shall be
enforced to the extent permissible and all other provisions of this Agreement shall continue to be
enforceable to the extent possible.
8.7 Counterparts. This Agreement may be executed in one or more counterparts, all of
which taken together shall constitute one and the same Agreement.
8.8 Assignment. Neither this Agreement nor any duties or obligations hereunder may be
assigned by either party without the other party’s prior written consent; provided, however, that
Luminex may assign this Agreement to either (i) a wholly-owned subsidiary of Luminex (provided,
however, that such assignment shall not relieve Luminex of its obligations hereunder) or (ii) a
Person acquiring substantially all of Luminex’s assets if such acquisition would constitute a
Change in Control.
- 13 -
8.9 Withholding. All compensation and benefits payable to Executive hereunder shall
be reduced by all federal, state, local and other withholdings and similar taxes and payments
required by applicable law.
- 14 -
IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year
first above written.
| LUMINEX CORPORATION | ||||||
| By: | /s/ Xxxxxxx X. Xxxxxxxx | |||||
| EXECUTIVE | ||||||
| /s/ Xxxx X. Xxxxxxx | ||||||
| Xxxx X. Xxxxxxx, Individually | ||||||
- 15 -
